1. Marcus DM, Goodman M, Jani AB, Osunkoya AO, Rossi PJ. A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008. Prostate Cancer Prostatic Dis. 2012;15:283–8.
2. Li Q, Zhang CS, Zhang Y. Molecular aspects of prostate cancer with neuroendocrine differentiation. Chin J Cancer Res. 2016;28:122–9.
3. Alanee S, Moore A, Nutt M, Holland B, Dynda D, El-Zawahry A, McVary KT. Contemporary incidence and mortality rates of neuroendocrine prostate cancer. Anticancer Res. 2015;35:4145–50.
4. Bostwick DG, Cheng L: Urologic surgical pathology. 3rd edition. Saunders: London. pp. 1 online resource (ix, 966 pages):1 online resource (ix, 966 pages).
5. Aumuller G, Doll A, Wennemuth G, Dizeyi N, Abrahamsson PA, Wilhelm B. Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat. Prostate. 2012;72:326–37.